Around 40 percent of women experience vaginal discomfort after menopause, but a new hormone-based treatment could bring relief.

Around 40 percent of women experience vaginal discomfort after menopause, but a new hormone-based treatment could bring relief.

Many current treatments include the use of local estrogen, which does help alleviate symptoms of burning, itching and dryness or pain with intercourse, but physicians are concerned that they may increase serum hormone levels. 

A study led by David Archer, MD, Professor of Obstetrics and Gynecology, found that the product TRX004HR provided vaginal symptom relief but did not significantly increase blood levels of estradiol.

“We tested the drug at several different doses and found in every case that it was highly effective, but didn’t increase serum hormone levels compared to women not using the medication.” says Dr. Archer. “This could be a very promising treatment for women experiencing these symptoms.”

The study will be published in the journal Menopause in May of 2017, and can be currently found online.